Navigation menus

Main menu links

• About COST
• Domains and Actions
• Participate
• Events
• Library
• Restricted Area
• e-COST

Section menu links

Events

Personalised Medicine: Better Healthcare for the Future - A Rational Approach Focusing on Bioinformatics, Medicinal Chemistry and Medicine

Personalised medicine, enabled by personalised ICT services, and providing genetic and genomic information of every individual, is designed to give each patient an individual therapeutically active drug while minimising the adverse effects.

Personalised medicine will only be successful when accurate diagnostic tests identify the patients who can benefit from targeted therapies and eventually reach the desired goal of prevention and prediction. The formidable challenges we are faced with in reaching this goal are numerous.

The scope of this conference is to connect high-level scientists across scientific domains, to support capacity building, and increase the impact of personalised medicine research on regulatory bodies, decision makers as well as the private sector.

The focus was on the following:

• Bring together researchers working on the latest scientific breakthrough developments of personalised medicine contributing to Europe’s research and innovation capacities;
• Broaden the concept of personalised medicine from the genetically reductionist version to one that includes other types of markers;
• Educate physicians and the public as a whole to these new developments. One of the major obstacles for making personalised medicine available for patients requires basic, translational, and also regulatory science, especially in the areas of ethical, legal and social issues;
• To bridge science, policy makers and society in the area of Personalised Medicine.

Sessions included:

• The evolving regulatory system
• Empowering the Patients
• ICT in action in Personalised Medicine
• Natural products as a source for new drugs
• Constellation thinking in the diagnosis and therapy
• Personalised health
• New Targets and inhibitors based on epigenetics
• Roundtables with stakeholders (Patients Associations, General Practitioners Associations, Clinician Associations)

Footer